ValGenesis, Inc. (“ValGenesis”), the market leader in Enterprise Validation Lifecycle Management Systems (VLMS), announced the closing of a $24 million investment from Morgan Stanley Expansion Capital. Proceeds will bolster sales and accelerate ValGenesis’ focus on innovation in digital validation technologies and global deployment.

ValGenesis delivers integrated and smart solutions that support the digital transformation of the life sciences industry. With a portfolio that covers the whole product lifecycle, ValGenesis has a digital or technical solution that brings value to each step of your validation and manufacturing processes and their related activities.



Valgenesis Inc. Secures $24 Million Investment From Morgan Stanley Expansion Capital

Description

Company Information

Related People

Funding Insights

Valgenesis Inc. Secures $24 Million Investment From Morgan Stanley Expansion Capital

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information